Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells
โ Scribed by Paul L. Black; Ellen S. Vitetta; James Forman; Chil-yong Kang; Richard D. May; Jonathan W. Uhr
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 841 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The role of the oligosaccharide portions of cell surface glycoproteins in the susceptibility of virusโinfected cells to Hโ2โrestricted cytolysis was investigated by using the antibiotic tunicamycin (TM). TM inhibits the addition of sugars to the polypeptides of glycoproteins. TM treatment of P 815 cells before and during infection with vesicular stomatitis virus (VSV) inhibited glycosylation of proteins and reduced by about 50% the lysis of infected P 815 cells by VSVโimmune, Hโ2โidentical killer cells. In contrast, TM treatment had a modest inhibitory effect on cytolysis of P 815 cells by alloimmune effector cells. TM treatment did not inhibit the surface expression of either Hโ2 or VSV glycoprotein. Thus, glycosylation of Hโ2 and/or viral glycoprotein is a prerequisite for the lysis of infected cells by Hโ2โidentical, VSVโimmune cytotoxic cells.
๐ SIMILAR VOLUMES
HCV encodes two glycoproteins, E1 and E2, that are believed to be exposed on the surface of virions. These molecules are likely to be involved in viral interactions with the host immune response and responsible for mediating viral entry into target cells. They are obvious major components for protot
## Abstract The cytotoxic response of human lymphocytes to the autologous lymphoblastoid cell line (LCL) was investigated with five EpsteinโBarr virus (EBV)โseropositive and four seronegative donors and an additional donor who seroconverted during the course of the study. LCL stimulation was carrie
We tested the hypothesis that Epstein-Barr virus (EBV) might actually infect leukemic hairy cells in vivo by examining those cells for the EBV-receptor, EBV nuclear antigen (EBNA) and membrane antigen (MA), for spontaneous transformation and rescue of infectious virus and for presence of EBV genome.